Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of N(2)-L-alanyl-L-glutamine dipeptide in trauma patients admitted to ICU
2009-017353-36Phase 2Active
- Sponsor
- Jon Perez Barcena
- Start
- Apr 2010
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of alanyl glutamine in Physical trauma and Healthcare-associated infection (HAI) (2 arms), sponsored by Jon Perez Barcena. Primary endpoint: Number of nosocomial infections. Started Apr 2010; status: active.
02
Drugs
alanyl glutamine
03
Conditions
Physical traumaHealthcare-associated infection (HAI)
Beyond the preview
Go deeper on 2009-017353-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-017353-36.